<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> is one of the most common and complex <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Using currently available evidence, leading medical societies have established recommendations for the optimal management of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>These guidelines have recently been updated by 4 consensus groups: the European Society of Cardiology, the American College of Chest Physicians, the Canadian Cardiovascular Society, and a task force of 3 societies from the United States: the American College of Cardiology Foundation, the American Heart Association, and the Heart Rhythm Society </plain></SENT>
<SENT sid="3" pm="."><plain>The present review focused on the similarities and differences among these recently updated guidelines </plain></SENT>
<SENT sid="4" pm="."><plain>Key revisions included updated information on newer treatments for rhythm control, treatment options to reduce <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> complications, and updated <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> management for thromboprophylaxis </plain></SENT>
</text></document>